External Source

Front-braf Trial: Does Immunotherapy Outperform Targeted Therapy In Braf-mutant Nsclc?

2025 0:26
Synopsis
Just out in The Lancet Oncology! The FRONT-BRAF study found that first-line immune checkpoint inhibitors (± chemotherapy) led ...

You Might Also Like

Targeting BRAF in NSCLC 3:10
Targeting Braf In Nsclc
2019
FRONT-BRAF: 1L immunotherapy +/- chemo vs. BRAF + MEK inhibitors in mNSCLC 2:21
Front-braf: 1l Immunotherapy +/- Chemo Vs. Braf + Mek Inhibi...
2025
Combination Therapy in BRAF-Mutant NSCLC 4:16
Combination Therapy In Braf-mutant Nsclc
2018
Novel treatment strategies for BRAF V600E-mutant NSCLC 1:26
Novel Treatment Strategies For Braf V600e-mutant Nsclc
2022
BRAF mutated melanoma: targeted or immunotherapy? 2:29
Braf Mutated Melanoma: Targeted Or Immunotherapy?
2017
Treating BRAF V600E-mutant NSCLC with dabrafenib and trametinib 2:56
Treating Braf V600e-mutant Nsclc With Dabrafenib And Trameti...
2022
How do doctors treat lung cancer with BRAF mutations? 1:19
How Do Doctors Treat Lung Cancer With Braf Mutations?
2024
Considering Targeted Agents in BRAF-Mutant NSCLC 6:43
Considering Targeted Agents In Braf-mutant Nsclc
2018
BRAF: A New Target to Treat in Lung Cancer 4:19
Braf: A New Target To Treat In Lung Cancer
2015
BRAF Molecular Testing in NSCLC 5:37
Braf Molecular Testing In Nsclc
2017
Standard of Care in BRAF V600E+ mNSCLC 3:30
Standard Of Care In Braf V600e+ Mnsclc
2020
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.